Fuso Pharmaceutical Industries, Ltd. (4538) - Financials, balance sheet (quarterly)

2,114 JPY

0.91%

Last update Jul 14, 3:21 PM JST

Market closed

Day range

2,114

2,095

2,118

Previous close

2,095

Open

2,095

Access this stock data via API

Fuso Pharmaceutical Industries, Ltd.

2,114.00

0.91%

Financials

Balance sheet

Fiscal date	Mar 2025	Sep 2024	Mar 2024	Dec 2023
Total assets	81.7B	76.0B	75.8B	77.7B
Current assets	48.3B	45.4B	44.9B	47.4B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	6.3B	4.6B	5.1B	6.7B
Other short term investments	—	—	—	—
Accounts receivable	26.5B	25.7B	24.3B	26.3B
Other receivables	—	—	—	—
Inventory	14.9B	14.3B	14.2B	13.2B
Prepaid assets	558M	—	460M	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	88M	758M	837M	1.2B
Non current assets	33.4B	30.6B	30.9B	30.4B
Properties	12M	5.1B	15M	7.5B
Land and improvements	8.8B	8.8B	8.8B	8.8B
Machinery furniture equipment	34.5B	—	34.0B	—
Construction in progress	174M	—	246M	—
Leases	—	—	—	—
Accumulated depreciation	-57.4B	—	-55.4B	—
Goodwill	1.5B	924M	600M	447M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	1.5B	—	600M	—
Investments and advances	—	—	—	—
Other non current assets	1.2B	—	1.2B	—
Total liabilities	48.7B	38.1B	39.1B	41.6B
Current liabilities	44.1B	33.1B	29.7B	31.2B
Accounts payable	4.0B	5.5B	7.4B	8.1B
Accrued expenses	—	—	—	—
Short term debt	18.8B	11.0B	6.7B	6.3B
Deferred revenue	—	—	—	—
Tax payable	949M	698M	270M	147M
Pensions	1.0B	932M	942M	455M
Other current liabilities	8.7B	14.9B	12.9B	16.2B
Non current liabilities	4.6B	5.0B	9.5B	10.4B
Long term provisions	108M	157M	108M	151M
Long term debt	2.5B	2.8B	7.0B	8.0B
Provision for risks and charges	—	—	—	—
Deferred liabilities	1.3B	—	1.3B	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	164M	1.6B	158M	1.5B
Shareholders equity
Common stock	10.8B	10.8B	10.8B	10.8B
Retained earnings	7.3B	17.8B	11.2B	16.4B
Other shareholders equity	—	—	—	—
Total shareholders equity	33.0B	37.9B	36.7B	36.1B
Additional paid in capital	15.0B	15.0B	15.0B	15.0B
Treasury stock	2.6B	2.6B	2.6B	2.8B
Minority interest	—	—	—	—